Finance

KPMG Becomes First Big Four Firm to Break Into US Legal Market

KPMG's Foray into Legal Services: A New Era in the US Legal Landscape Introduction to KPMG's Legal Venture In a significant move, KPMG, one of the...

Kepler Capital Keeps Their Buy Rating on CTP N.V. (CTPNV)

Kepler Capital's Optimistic Outlook on CTP N.V. In a recent update, Kepler Capital analyst Frederic Renard reaffirmed a "Buy" rating for CTP N.V., setting a...

PPHE Hotel (PPH) Gets a Buy from Kepler Capital

PPHE Hotel Group: A Promising Investment Opportunity PPHE Hotel Group, a well-known player in the hospitality industry, has recently garnered attention from financial analysts and...

Veolia Environnement (0NY8) Gets a Buy from Kepler Capital

Analyst Action on Veolia Environnement Juan Rodriguez, an analyst at Kepler Capital, recently made a notable move by maintaining a "Buy" rating on Veolia Environnement,...

Kepler Capital Sticks to Its Buy Rating for Befesa S.A. (BFSA)

Befesa S.A.: A Comprehensive Overview and Investment Analysis Introduction to Befesa S.A. Befesa S.A., a prominent player in the industrial sector, has garnered significant attention from...

Kepler Capital Sticks to Their Buy Rating for Subsea 7 (0OGK)

Subsea 7: A Comprehensive Overview Subsea 7, a prominent player in the subsea services industry, has recently gained attention from financial analysts and investors. The...

Kepler Capital Sticks to Their Hold Rating for Vallourec (0NR2)

Vallourec: An Overview and Recent Financial Performance Vallourec is a prominent player in the energy transition and industrial markets, specializing in the production of high-value-added...

Kepler Capital Sticks to Its Hold Rating for Novonesis (0Q4U)

Novonesis: A Comprehensive Analysis of Analyst Ratings and Market Performance Introduction to Novonesis and Recent Analyst Activity Novonesis, a company listed under the ticker symbol 0Q4U,...

Redcare Pharmacy (0RJT) Gets a Hold from Kepler Capital

Introduction to Redcare Pharmacy and Recent Analyst Note Redcare Pharmacy, a European healthcare company, has recently gained attention from the financial community following a notable...

Kepler Capital Keeps Their Hold Rating on Bystronic (0QW1)

Analyst Rating and Price Target for Bystronic (0QW1) In a recent report dated February 27, Torsten Sauter, an analyst at Kepler Capital, reaffirmed his...

Related Posts